Year-over-year net earnings per share growth for the last 12 months: BD (BDX)
Balanced global sales provide Becton Dickinson & Co (BDX) with steady cash flows. The non-cyclical nature of the business ensures high macro-resilience even during crises. The quarterly EPS growth rate reflects the issuer's real economics, where the value of 47.90 characterizes this level. Stable global sales of mass-market disposable syringes and blood collection systems confirm the company's fundamental reliability.
Analytical breakdowns and data insights for company Becton Dickinson & Co (BDX)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- book capitalization indicators:
- company total debt and liquidity indicators:
Debt to Equity Becton Dickinson & Co|BDX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Becton Dickinson & Company|BDX - Company Cumulative Debt|Debt to Book Capitalization Ratio Becton, Dickinson and Company|BDX - Company Long-Term Indebtedness|Company Current Liabilities Becton Dickinson|Quick Liquidity bd.com
- earnings and market multiples details:
BDX - Net Financial Result|Projected Future Earnings Becton Dickinson & Co|BDX - Price to Earnings Ratio|Forward P/E Multiple BD|BDX - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple BD|BDX - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Becton Dickinson|BDX - Earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months bd.com|BDX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Becton Dickinson & Co
- sales revenue and business income indicators:
Comprehensive company analysis:Becton Dickinson & Co
Quarterly earnings per share (EPS) growth reflects the monetization efficiency of medical consumables and laboratory equipment at Becton Dickinson & Co (BDX). This metric measures net income per share dynamics, filtering out short-term market noise. Comparing quarterly EPS reveals the true fundamental resilience of the business. This indicator demonstrates the company's ability to convert syringe and catheter sales into actual shareholder returns. Stable growth confirms operational profitability and the issuer's low vulnerability.
Key competitors
Intuitive Surgical (ISRG) - Year-over-year earnings per share growth for the last twelve months|DHR - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months STE|WST (westpharma.com) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Baxter (BAX)|Year-over-year earnings per share growth rate for the last twelve months MASI|Year-over-year earnings per share growth for the last twelve months Stevanato STVN|Quarterly EPS earnings growth Teleflex Corp TFX|MMSI: Year-over-year net earnings per share growth for the last 12 months|NVST - Quarterly EPS earnings growth|ICU Medical Inc (ICUI) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Dentsply Sirona|LMAT (lemaitre.com) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months AtriCure Medical ATRC|Year-over-year earnings per share growth for the last twelve months STAAR Surgical (STAA)|ChromaDex - Year-over-year earnings per share growth for the last 12 months|ZimVie Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ANGO (AngioDynamics Inc)|CERS - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Alpha Teknova Inc TKNO|monogramorthopedics.com (MGRM) - Year-over-year earnings per share growth for the last twelve months|STSS - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months InfuSystem Holdings, Inc.|UTMD (Utah Medical Products, Inc.) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months KORU Medical Systems, Inc. (KRMD)|Nyxoah S.A - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Microbot Medical Inc. MBOT|Net earnings per share growth for the trailing year Pro-Dex, Inc.|Zentek Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Elutia ELUT|MLSS (Milestone Scientific Inc.) - Year-over-year net earnings per share growth for the last 12 months|NXGL (NEXGEL, Inc.) - Year-over-year earnings per share growth for the last twelve months|RVP (Retractable Tech) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months HBIO (Harvard Bioscience, Inc.)|Year-over-year net earnings per share growth for the last 12 months FEMY (Femasys)|MHUA - Earnings per share growth in annualized terms for the last twelve months|Predictive Oncology Corp - Year-over-year net earnings per share growth for the last 12 months|CJMB - Year-over-year net earnings per share growth for the last 12 months|ATRI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months NeuroMetrix NURO
